ALEC vs EXAS · rev $4.4M vs rev $2.76B
Alector Inc (ALEC) versus EXACT Sciences Corporation (EXAS) — a side-by-side from cached financials, not a winner call.
Alector Inc (ALEC) is a biotechnology company listed on US.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Latest reported ALEC revenue for 2026-06-30 was $4.4M. Net income was -$45.9M. ALEC currently screens at market cap $216.5M.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
ALEC currently screens at market cap $216.5M. EXAS currently screens at market cap $20.03B.
Not investment advice. Open the ALEC and EXAS stock pages for the full models.
Not investment advice.